Skip to content

Local Anaesthetic for Transvaginal Egg Collection in IVF

A Randomised Controlled Trial of Intravaginal Lignocaine Injection Versus Placebo for Analgesia During Oocyte Recovery in an IVF Cycle

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00554424
Enrollment
75
Registered
2007-11-06
Start date
2002-03-31
Completion date
2002-07-31
Last updated
2007-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

oocyte retrieval, pain relief, Local anaesthetic

Brief summary

The purpose of this study is to see whether injecting local anaesthetic into the vaginal tissues,just prior to transvaginal egg collection,will decrease the amount of pain experienced by women having their eggs collected on an IVF cycle. All women will also receive intravenous sedation as required as well as a sleeping tablet thirty minutes prior to the procedure which is our routine procedure for egg collection.

Detailed description

Transvaginal oocyte retrieval is the most common method of oocyte collection in IVF cycles. A variety of different methods are used to provide analgesia/anesthesia for oocyte collection. Our unit has always used an oral pre-medication followed by intravenous fentanyl during the procedure but this doesn't seem to provide adequate analgesia for some women. The aim of this study was to compare the addition of intravaginal local anaesthetic injection versus saline placebo to our usual analgesia regime to see whether less intravenous fentanyl was required and whether the women experienced less pain during oocyte collection.

Interventions

20 mls of 1% lignocaine solution for injection, 10mls into each side of upper vagina, under ultrasound guidance immediately prior to transvaginal oocyte retrieval under ultrasound guidance from each ovary

DRUGnormal saline

20mls of normal saline solution, 10mls injected each side into upper vagina under ultrasound guidance, immediately prior to ultrasound guided transvaginal oocyte retrieval from each ovary

Sponsors

The Fertility Centre, New Zealand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* About to undergo transvaginal oocyte retrieval

Exclusion criteria

* Already undergone oocyte retrieval and participated in study (i.e. 2nd or more oocyte collection procedure during study period) * Allergy to lignocaine * Oocytes only to be collected from one ovary * Procedure expected to be exceptionally painful

Design outcomes

Primary

MeasureTime frame
Total dose of iv fentanyl used during oocyte collectionLength of oocyte collection (minutes)

Secondary

MeasureTime frame
Length of oocyte collection procedureTime taken (minutes)
Occurence of nausea or vomitingDuring oocyte collection procedure
Administration of atropine or anti -emeticDuring oocyte collection procedure
Time spent in recovery roomTime from end of oocyte collection until discharge home
No of oocytes collectedDuring oocyte collection procedure
Pain score (cm on a Visual Analogue Scale) at 6 different points during oocyte collectionActual point in time
Pregnancy outcome7 weeks gestation
Number of embryos frozenWithin 6 days of oocyte collection
Pulse rate at beginning and end of egg collectionPoint in time
Maximum pulse rate during oocyte collectionPoint in time during oocyte collection procedure
Number of oocytes fertilisedAssessed 18 hours after oocyte collection

Countries

New Zealand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026